Garry Menzel

(Dr. Garry Menzel Ph.D.)

Currently holds a position at TCR2 Therapeutics Inc

Positions
Position Company Period
President, Chief Executive Officer, Director TCR2 Therapeutics Inc Dec. 1, 2018 -
Chief Executive Officer, Director TCR2 Therapeutics Inc Jan. 1, 2016 - Dec. 1, 2018
Executive Vice President, Chief Business and Strategy Officer Axcella Health Inc Oct. 1, 2015 - Jan. 1, 2018
Chief Financial Officer DaVita Inc Nov. 1, 2013 - March 30, 2015
Chief Operating Officer, Executive Vice President - Finance Regulus Therapeutics Inc Jan. 2, 2009 - June 21, 2013
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-07-10 2023-07-10
S Sale
47,702 -38.9%
0.91
43,447 USD 		47,702 -38.9% 0.91 43,447 USD
2022-12-13 2022-12-13
PS Planned sale
11,000 -7.3%
1.06
11,682 USD 		11,000 -7.3% 1.06 11,682 USD
2022-12-13 2022-12-12
PS Planned sale
10,613 -6.6%
1.10
11,674 USD 		10,613 -6.6% 1.10 11,674 USD
2022-12-13 2022-12-09
PS Planned sale
10,325 -6.0%
1.13
11,678 USD 		10,325 -6.0% 1.13 11,678 USD
2022-12-09 2022-12-08
PS Planned sale
9,314 -5.2%
1.25
11,680 USD 		9,314 -5.2% 1.25 11,680 USD
2022-12-09 2022-12-07
PS Planned sale
9,111 -4.8%
1.28
11,680 USD 		9,111 -4.8% 1.28 11,680 USD
2022-12-07 2022-12-06
PS Planned sale
14,886 -7.3%
1.35
20,081 USD 		14,886 -7.3% 1.35 20,081 USD
2022-12-07 2022-12-05
PS Planned sale
8,530 -4.0%
1.37
11,703 USD 		8,530 -4.0% 1.37 11,703 USD
2022-12-05 2022-12-02
PS Planned sale
8,408 -3.8%
1.39
11,687 USD 		8,408 -3.8% 1.39 11,687 USD